PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Recruiting · NCT06721689 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors | Disease Attributes, Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, epithelial neoplasm, myomatous neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor, rhabdomyosarcoma, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT06721689 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peel Therapeutics Inc | 3 |
| Theodore Laetsch | 1 |
| University of Pennsylvania | 502 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Texas Children's Hospital | Houston | United States | 187 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Utah Hospital | Salt Lake City | United States | 26 |